Disputes between shareholders — deadlocks, breaches of SHA, unfair exclusion, dividend disputes and forced exits — determine the commercial future of the enterprise. AMLEGALS advises on enforcement, negotiation and dispute resolution.
Shareholder disputes in Indian companies arise from a limited set of recurring patterns: management deadlock between equal partners, exclusion of minority shareholders from decision-making, breach of shareholder-agreement obligations (pre-emption rights, board-nomination rights, information rights), dividend-suppression strategies, related-party transactions that benefit the majority at the minority’s expense, and disagreements over exit mechanisms and valuation.
AMLEGALS advises both majority and minority shareholders on the full spectrum of dispute resolution: enforcement of shareholder-agreement rights through arbitration or specific performance, oppression petitions before the NCLT, negotiated exits with valuation advisory, and preventive structuring through well-drafted SHA and articles provisions. The practice integrates company law with the firm’s arbitration and commercial-litigation capabilities.
Enforcing shareholder-agreement obligations including pre-emption rights, tag-along/drag-along, board nomination and information rights.
Advising on contractual deadlock-resolution mechanisms and, where they fail, on statutory and judicial remedies.
Advising on exit mechanisms including put/call options, buyback, third-party sale and NCLT-directed buyback under Section 242.
Advising on share-valuation methodologies, challenging valuations in NCLT and arbitral proceedings.
Filing or defending oppression and mismanagement petitions under Sections 241–242 as a shareholder-dispute remedy.
Conducting arbitrations arising from shareholder agreements, joint-venture agreements and investment agreements.
Remedies include enforcement of SHA through arbitration or specific performance, oppression petitions under Sections 241–242 of the Companies Act 2013, winding up on the just-and-equitable ground, derivative actions under Section 245, and contractual remedies under the SHA including put/call options, drag-along and buyback. The choice of remedy depends on the nature of the dispute, the shareholding structure and the contractual framework.
Pure contractual disputes under a shareholder agreement are arbitrable. However, oppression and mismanagement proceedings under Sections 241–242 are not arbitrable as they involve statutory jurisdiction (Booz Allen v SBI Home Finance, 2011 SC). Where a dispute involves both contractual breaches and oppression, the contractual claims may be referred to arbitration while the oppression petition proceeds before the NCLT.
Valuation methodologies include discounted cash flow (DCF), net asset value (NAV), comparable-company multiples, precedent transactions and a blended approach. The Companies Act does not prescribe a specific methodology for Section 242 buybacks. The NCLT has adopted fair value determined by independent valuers, and the valuation is frequently the most contested element of a shareholder dispute.
A deadlock arises when co-equal shareholders or directors cannot agree on a material decision, and the deadlock-resolution mechanism in the SHA (escalation, mediation, expert determination, Russian roulette, Texas shootout) has failed or does not exist. Where contractual mechanisms are exhausted, the options include oppression proceedings, winding up on the just-and-equitable ground, or a negotiated buyout. Prevention through well-drafted SHA provisions is always preferable to litigation.
Yes, through a drag-along clause in the SHA if validly invoked. Under the Companies Act, Section 236 provides for acquisition of minority shareholding where the acquirer holds 90% or more. The NCLT can also direct buyback of a minority’s shares under Section 242 as part of an oppression remedy. In all cases, the price must be fair and the process must comply with the statutory or contractual requirements.
No. No engagement is treated as accepted until conflicts, scope and terms are confirmed in writing.
Share the details for a confidential assessment.